By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > General > Theophylline

Theophylline

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|600 words

Theophylline Drug Profile

What is Theophylline?

Theophylline is a bronchodilator medication belonging to the methylxanthine class of drugs, closely related to caffeine. It is primarily used to treat respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD) by helping to open airways and improve breathing. This medication has been used for decades as both a maintenance therapy and for acute respiratory symptoms.

Uses

Theophylline is approved for several respiratory conditions:

  • Asthma maintenance therapy: Used as a long-term treatment to prevent asthma symptoms and reduce the frequency of attacks
  • Chronic obstructive pulmonary disease (COPD): Helps improve airflow and reduce symptoms in patients with chronic bronchitis and emphysema
  • Acute bronchospasm: Can be used in hospital settings to treat severe breathing difficulties
  • Apnea of prematurity: Sometimes used in premature infants who experience breathing interruptions
  • Reversible airway obstruction: Treats various conditions that cause temporary airway narrowing

How it works

Theophylline works by blocking an enzyme called phosphodiesterase, which leads to increased levels of a chemical messenger that relaxes the smooth muscles surrounding the airways. This relaxation allows the airways to open wider, making it easier to breathe. The medication also has mild anti-inflammatory effects and may stimulate the respiratory center in the brain to improve breathing patterns.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Nausea and vomiting
  • Headache
  • Insomnia and restlessness
  • Rapid heart rate (tachycardia)
  • Stomach irritation and abdominal pain
  • Nervousness and irritability
  • Tremors
  • Increased urination

Serious side effects requiring immediate medical attention:

  • Seizures
  • Severe irregular heart rhythms (arrhythmias)
  • Persistent vomiting
  • Chest pain
  • Signs of toxicity such as confusion or extreme agitation

Warnings and precautions

  • Narrow therapeutic window: Theophylline has a small margin between effective and toxic doses, requiring regular blood level monitoring to ensure safety and effectiveness
  • Heart conditions: Patients with heart disease, high blood pressure, or irregular heart rhythms should use this medication with extreme caution
  • Liver and kidney disease: Reduced liver or kidney function can affect how the body processes theophylline, potentially leading to dangerous accumulation
  • Pregnancy and breastfeeding: Should only be used when benefits clearly outweigh risks, as it crosses the placenta and enters breast milk
  • Age considerations: Elderly patients and young children may be more sensitive to theophylline’s effects and require careful dose adjustments

Interactions

Theophylline has numerous important drug interactions:

  • Ciprofloxacin and other fluoroquinolone antibiotics: Can significantly increase theophylline levels, leading to toxicity
  • Cimetidine: Reduces theophylline clearance, increasing blood levels and risk of side effects
  • Phenytoin and carbamazepine: May decrease theophylline effectiveness by increasing its metabolism
  • Erythromycin and clarithromycin: Can increase theophylline concentrations and toxicity risk
  • Beta-blockers: May counteract theophylline’s bronchodilator effects
  • Caffeine: Can increase nervous system stimulation and heart-related side effects
  • St. John’s Wort: May reduce theophylline effectiveness by increasing its metabolism
  • Smoking: Tobacco use increases theophylline metabolism, requiring higher doses for effectiveness

Check interactions with the GMJ Interaction Checker

Dosage

Theophylline dosing is highly individualized based on patient factors, condition severity, and blood level monitoring. Typical starting doses for adults range from 300-400 mg daily, divided into multiple doses or given as extended-release formulations. Maintenance doses usually range from 400-600 mg daily, though some patients may require up to 900 mg daily. Blood levels should be monitored regularly, with target therapeutic levels typically between 10-20 mcg/mL. Dosage adjustments are frequently necessary based on individual response, side effects, and blood level results. All dosing decisions should be made by a healthcare provider who can properly monitor treatment response and safety.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Theophylline." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/theophylline-2/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Revolution Medicines Ships Experimental Pancreatic Cancer Drug Under Early Access

Revolution Medicines begins expanded access program for daraxonrasib targeting KRAS G12C mutations.…

NHS Patient Watchdog Abolition Sparks Concerns Over Health Service Accountability

Local councils warn that government plans to abolish NHS patient watchdogs will…

DNA Test Could Spare 6,600 Breast Cancer Patients From Unnecessary Chemotherapy

New genetic testing could spare 6,600 UK breast cancer patients annually from…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Famotidine

By
Prof. Giorgi Pkhakadze
02/06/2026

Amikacin

By
Prof. Giorgi Pkhakadze
02/06/2026

Sulfasalazine

By
Prof. Giorgi Pkhakadze
02/06/2026

Pioglitazone

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up